Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8169)
All Articles published online
|
Publishing Process of This Article
|
Jun 7, 2019 (publication date) through Dec 17, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ma YJ, Cao ZX, Li Y, Feng SY. Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis. World J Gastroenterol 2019; 25(21): 2675-2682 [PMID: 31210718 DOI: 10.3748/wjg.v25.i21.2675] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i21/2675.htm |
| Number | Citing Articles |
| 1 |
Wansheng Yan, Zhihui Yao, Qiutong Ou, Gang Ye. Establishment and validation of a prognosis nomogram for MIMIC-III patients with liver cirrhosis complicated with hepatic encephalopathy. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02967-1
|
| 2 |
Rui Dai, Alan A. Sag, Jonathan G. Martin, Nicholas T. Befera, Waleska M. Pabon-Ramos, Paul V. Suhocki, Tony P. Smith, Charles Y. Kim, Andrew J. Muir, James Ronald. Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohort. Clinical Imaging 2021; 77: 187 doi: 10.1016/j.clinimag.2021.04.034
|
| 3 |
Naina Mohamed Pakkir Maideen. Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors. Chonnam Medical Journal 2023; 59(2): 115 doi: 10.4068/cmj.2023.59.2.115
|
| 4 |
Lindsey Sellers Coppiano, Dianne May. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Side Effects of Drugs Annual 2020; 42: 361 doi: 10.1016/bs.seda.2020.08.012
|
| 5 |
Akira Sakamaki, Kenya Kamimura, Takeshi Yokoo, Akihiko Osaki, Seiichi Yoshikawa, Yoshihisa Arao, Toru Setsu, Hiroteru Kamimura, Nobuo Waguri, Manabu Takeuchi, Kazuhiro Funakoshi, Shuji Terai. The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitors. Medicine 2021; 100(32): e26902 doi: 10.1097/MD.0000000000026902
|
| 6 |
Mitchell L. Schubert. Proton pump inhibitors. Current Opinion in Gastroenterology 2019; 35(6): 509 doi: 10.1097/MOG.0000000000000580
|
| 7 |
Mohammad Amin Fallahzadeh, Robert S. Rahimi. Hepatic Encephalopathy and Nutrition Influences: A Narrative Review. Nutrition in Clinical Practice 2020; 35(1): 36 doi: 10.1002/ncp.10458
|
| 8 |
Xiucong Fan, Danxia Chen, Siwei Bao, Xiaohui Dong, Fang Fang, Rong Bai, Yuyi Zhang, Xiaogang Zhang, Weijun Tang, Yabin Ma, Xiaobo Zhai. Prospective prescription review system correlated with more rational PPI medication use, better clinical outcomes and reduced PPI costs: experience from a retrospective cohort study. BMC Health Services Research 2023; 23(1) doi: 10.1186/s12913-023-09931-5
|
| 9 |
Richard Moreau, Marta Tonon, Aleksander Krag, Paolo Angeli, Marina Berenguer, Annalisa Berzigotti, Javier Fernandez, Claire Francoz, Thierry Gustot, Rajiv Jalan, Maria Papp, Jonel Trebicka. EASL Clinical Practice Guidelines on acute-on-chronic liver failure. Journal of Hepatology 2023; 79(2): 461 doi: 10.1016/j.jhep.2023.04.021
|
| 10 |
Yun Su, Yueqiao Chen, Jinghui Zheng, Chun Yao. Association between proton pump inhibitors and risk of hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt: a protocol for a systematic review and meta-analysis. BMJ Open 2024; 14(4): e078412 doi: 10.1136/bmjopen-2023-078412
|
| 11 |
Yuan Bin Liu, Ming Kai Chen. The impact of proton pump inhibitors in liver diseases and the effects on the liver. Journal of Digestive Diseases 2022; 23(4): 196 doi: 10.1111/1751-2980.13093
|
| 12 |
Mohammad Amin Fallahzadeh, Robert S. Rahimi. Hepatic Encephalopathy: Current and Emerging Treatment Modalities. Clinical Gastroenterology and Hepatology 2022; 20(8): S9 doi: 10.1016/j.cgh.2022.04.034
|
| 13 |
L. Veremme, A. Baudouin, A. Janoly-Dumenil, B. Charpiat. Thésaurus d’interventions pharmaceutiques associées aux prescriptions injustifiées d’inhibiteurs de la pompe à protons. Annales Pharmaceutiques Françaises 2023; 81(3): 552 doi: 10.1016/j.pharma.2022.11.006
|
| 14 |
Rok Orel, Marc A. Benninga, Ilse J. Broekaert, Frederic Gottrand, Alexandra Papadopoulou, Carmen Ribes-Koninckx, Mike Thomson, Michael Wilschanski, Nikhil Thapar. Drugs in Focus: Proton Pump Inhibitors. Journal of Pediatric Gastroenterology & Nutrition 2021; 72(5): 645 doi: 10.1097/MPG.0000000000003063
|
| 15 |
Lucia Lapenna, Simone Di Cola, Manuela Merli. The crucial role of risk factors when dealing with hepatic Encephalopathy. Metabolic Brain Disease 2024; 40(1) doi: 10.1007/s11011-024-01446-0
|
| 16 |
Vincenzo Savarino, Elisa Marabotto, Manuele Furnari, Fabiana Zingone, Patrizia Zentilin, Edoardo Savarino. Latest insights into the hot question of proton pump inhibitor safety – a narrative review. Digestive and Liver Disease 2020; 52(8): 842 doi: 10.1016/j.dld.2020.04.020
|
| 17 |
Ummi Maimunah, Andreas Agung Kurniawan, Andrio Palayukan. Adverse Effects of Long-term Proton Pump Inhibitors in Chronic Liver Disease Patients – A Preliminary Article Review. Review of Clinical Pharmacology and Pharmacokinetics - International Edition 2024; 38(1): 87 doi: 10.61873/WWAY6273
|
| 18 |
Yun Hong, Ziqi Ye, Zhe Gao, Yuefeng Rao. Continuous improvement on the rationality of prophylactic injectable PPIs usage by a clinical pharmacist-led guidance team at a Chinese tertiary teaching hospital. Journal of International Medical Research 2020; 48(10) doi: 10.1177/0300060520954729
|
| 19 |
Xiaoli Wu, Daofu Zhang, Yuexiao Yu, Lianqing Lou, Xiaofei Li. Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studies. Bioscience Reports 2020; 40(6) doi: 10.1042/BSR20193890
|
| 20 |
Rong-Qiang Liu, Yi Shao. Results of meta-analysis should be treated critically. World Journal of Gastroenterology 2020; 26(9): 992-994 doi: 10.3748/wjg.v26.i9.992
|
| 21 |
Mitchell L. Schubert. Proton pump inhibitors: misconceptions and proper prescribing practice. Current Opinion in Gastroenterology 2020; 36(6): 493 doi: 10.1097/MOG.0000000000000676
|
| 22 |
Reidar Fossmark, Tom C. Martinsen, Helge L. Waldum. Adverse Effects of Proton Pump Inhibitors—Evidence and Plausibility. International Journal of Molecular Sciences 2019; 20(20): 5203 doi: 10.3390/ijms20205203
|
| 23 |
Gasser El-Azab. Proton Pump Inhibitors in Patients with Cirrhosis: Pharmacokinetics, Benefits and Drawbacks. Current Gastroenterology Reports 2024; 26(12): 323 doi: 10.1007/s11894-024-00943-7
|
| 24 |
倩倩 何. Research Progress on Risk Factors of Hepatic Encephalopathy after TIPS. Advances in Clinical Medicine 2023; 13(10): 15870 doi: 10.12677/ACM.2023.13102218
|